Brain Tumor
Showing of 10 results
![Medtronic Stealth Autoglide platform](/-/media/images/for-clinicians/articles-and-news/2021/01/autoguide-stealthstation-hd-700x750.jpg?mw=304&h=325&w=304&la=en&hash=5DDC221071D5CAAEEE3C2EF378339F91)
UH Introduces Stealth Autoguide™ for Precision Neurosurgery
New robotic guidance platform reduces risk for patients undergoing complex brain surgery - Innovations in Neurology & Neurosurgery | Winter 2021
![](/-/media/images/for-clinicians/articles-and-news/2022/08/lab-467245909-700x750.jpg?mw=304&h=326&w=304&la=en&hash=35CEEAD83535757561D6EB6DB87DD65C)
UH Seidman Cancer Center Opens New Trial with PVSRIPO, a Viral-based Immunotherapy in Combination with Pembrolizumab for Patients with Recurrent GBM
The two therapies may be able to generate a potent and specific anti-tumor response in rGBM patients, given their different but complimentary mechanisms of action - Innovations in Cancer | Fall 2020
![](/-/media/images/for-clinicians/articles-and-news/2020/07/brain-tumor-image-summer-2018-article-700x750.jpg?mw=304&h=325&w=304&la=en&hash=4706A430C74244FCCE1E1E620D31E040)
CETNO Advances Brain Tumor Translational Research from the Basic Science into Clinical Care
UH Research & Education Update | July 2020
![](/-/media/images/physician-headshots/s/sloan-andrew03132012-uh-sloan-mri700x750.jpg?mw=304&h=326&w=304&la=en&hash=7DAE51A658AD679C61A2970F882C8F54)
UH Neurosurgeon Testing Novel Gene Therapy Treatment for Glioblastoma
New $2.7 million grant from the National Cancer Institute will help validate promising approach - Innovations in Cancer | Summer 2019
![](/-/media/images/physician-headshots/s/sloan-andrew03132012-uh-sloan-mri700x750.jpg?mw=304&h=326&w=304&la=en&hash=7DAE51A658AD679C61A2970F882C8F54)
5-ALA: Giving Surgeons an Edge
5-ALA helps surgeons visualize boundaries of invading tumors for more complete removal - Innovations in Neurology & Neurosurgery - Winter 2019
![](/-/media/images/for-clinicians/articles-and-news/2020/07/brain-tumor-image-summer-2018-article-700x750.jpg?mw=304&h=325&w=304&la=en&hash=4706A430C74244FCCE1E1E620D31E040)
Newly FDA-approved Imaging Agent That Makes Brain Tumors Glow Hot Pink
Distinguishes tumor from healthy tissue to improve tumor removal The imaging agent 5-Aminolevulinic Acid (5-ALA), which helps neurosurgeons see the edges of a tumor more clearly to improve removal, was used in brain cancer surgery at University...
![](/-/media/images/for-clinicians/articles-and-news/2018/05/brain-scan.jpg?mw=304&h=202&w=304&la=en&hash=E45CD102252248D9888D8A639A76490E)
Multi-Disciplinary Care for Patients with Primary and Metastatic Tumors of the Brain & Spine
UH Neurological Institute - Summer 2018 University Hospital’s Neurological Institute works closely with UH Seidman Cancer Center to offer cutting-edge treatments for primary and metastatic cancers of the brain and spine and for non-metastatic...
![](/-/media/images/for-clinicians/articles-and-news/2023/01/seidmanexr-041311-027-lores700x750.jpg?mw=304&h=326&w=304&la=en&hash=5461723F3CA82432AFF7F73B0050CE89)
Descriptive Data
Magnetic resonance fingerprinting technology developed in Cleveland shows promise in adult brain tumors - Innovations in Cancer | Spring 2017